{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T01:40:59Z","timestamp":1760492459731,"version":"build-2065373602"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04271-6","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T13:38:35Z","timestamp":1760449115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of cardiometabolic index with non-alcoholic fatty liver disease among Iranian adults of the amol cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Catherine","family":"Behzad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zainab","family":"Shateri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nima","family":"Motamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansooreh","family":"Maadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Ajdarkosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Sobhrakhshankhah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azam","family":"Doustmohammadian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehran","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"issue":"10290","key":"4271_CR1","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW-S, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212\u201324.","journal-title":"Lancet"},{"key":"4271_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/jgh.12271","volume":"28","author":"E Hashimoto","year":"2013","unstructured":"Hashimoto E, Taniai M, Tokushige K. Characteristics and diagnosis of NAFLD\/NASH. J Gastroenterol Hepatol. 2013;28:64\u201370.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"4271_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology"},{"issue":"Suppl","key":"4271_CR4","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","volume":"29","author":"ML Teng","year":"2023","unstructured":"Teng ML, Ng CH, Huang DQ, Chan KE, Tan DJ, Lim WH, Yang JD, Tan E, Muthiah MD. Global incidence and prevalence of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2023;29(Suppl):S32.","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"4271_CR5","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/liv.15852","volume":"44","author":"ZM Younossi","year":"2024","unstructured":"Younossi ZM, Golabi P, Paik J, Owrangi S, Yilmaz Y, El-Kassas M, et al. Prevalence of metabolic dysfunction\u2010associated steatotic liver disease in the middle East and North Africa. Liver Int. 2024;44(4):1061\u201370.","journal-title":"Liver Int"},{"issue":"1","key":"4271_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2023.06.009","volume":"14","author":"SP Tabaeian","year":"2024","unstructured":"Tabaeian SP, Rezapour A, Azari S, Martini M, Saran M, Behzadifar M, et al. Prevalence of non-alcoholic fatty liver disease in Iran: a systematic review and meta-analysis. J Clin Exp Hepatol. 2024;14(1):101209.","journal-title":"J Clin Exp Hepatol"},{"key":"4271_CR7","doi-asserted-by":"publisher","first-page":"154170","DOI":"10.1016\/j.metabol.2020.154170","volume":"111","author":"A Mantovani","year":"2020","unstructured":"Mantovani A, Scorletti E, Mosca A, Alisi A, Byrne CD, Targher G. Complications, morbidity and mortality of nonalcoholic fatty liver disease. Metabolism. 2020;111:154170.","journal-title":"Metabolism"},{"issue":"43","key":"4271_CR8","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i43.9488","volume":"22","author":"I Mikolasevic","year":"2016","unstructured":"Mikolasevic I, Milic S, Wensveen TT, Grgic I, Jakopcic I, Stimac D, et al. Nonalcoholic fatty liver disease-a multisystem disease? World J Gastroenterol. 2016;22(43):9488.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4271_CR9","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1):S47-64.","journal-title":"J Hepatol"},{"issue":"5","key":"4271_CR10","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1161\/ATVBAHA.114.305200","volume":"35","author":"MT Long","year":"2015","unstructured":"Long MT, Wang N, Larson MG, Mitchell GF, Palmisano J, Vasan RS, et al. Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study. Arterioscler Thromb Vasc Biol. 2015;35(5):1284\u201391.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"4271_CR11","first-page":"412","volume":"31","author":"M Saha","year":"2022","unstructured":"Saha M, Hossain M, Gope S, Ahmed M, Azad K, Chowdhury Z, et al. Prevalence of sonologically detected non-alcoholic fatty liver disease among school children of Sylhet City. Mymensingh Med Journal: MMJ. 2022;31(2):412\u20135.","journal-title":"Mymensingh Med Journal: MMJ"},{"issue":"11","key":"4271_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20112841","volume":"20","author":"A Lonardo","year":"2019","unstructured":"Lonardo A, Mantovani A, Lugari S, Targher G. Nafld in some common endocrine diseases: prevalence, pathophysiology, and principles of diagnosis and management. Int J Mol Sci. 2019;20(11):2841.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"4271_CR13","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cgh.2012.12.031","volume":"11","author":"EM Koehler","year":"2013","unstructured":"Koehler EM, Schouten JN, Hansen BE, Hofman A, Stricker BH, Janssen HL. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. Clin Gastroenterol Hepatol. 2013;11(9):1201\u20134.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4271_CR14","unstructured":"Fennoun H, El Mansouri S, Tahiri M, Haraj NE, El Aziz S, Hadad F, Hliwa W, Badr W, Chadli A. Interest of hepatic steatosis index (HSI) in screening for metabolic steatopathy in patients with type 2 diabetes. Pan Afr Med J. 2020;37(1):270."},{"issue":"7","key":"4271_CR15","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"J-H Lee","year":"2010","unstructured":"Lee J-H, Kim D, Kim HJ, Lee C-H, Yang JI, Kim W, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42(7):503\u20138.","journal-title":"Dig Liver Dis"},{"issue":"1","key":"4271_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5009\/gnl19301","volume":"15","author":"JW Chang","year":"2020","unstructured":"Chang JW, Lee HW, Kim BK, Park JY, Kim DY, Ahn SH, et al. Hepatic steatosis index in the detection of fatty liver in patients with chronic hepatitis B receiving antiviral therapy. Gut Liver. 2020;15(1):117.","journal-title":"Gut Liver"},{"issue":"1","key":"4271_CR17","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/jgh.13814","volume":"33","author":"L Svikl\u0101ne","year":"2018","unstructured":"Svikl\u0101ne L, Olmane E, Dz\u0113rve Z, Kup\u010ds K, P\u012br\u0101gs V, Sokolovska J. Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes. J Gastroenterol Hepatol. 2018;33(1):270\u20136.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"4271_CR18","first-page":"255","volume":"17","author":"C Radu","year":"2008","unstructured":"Radu C, Grigorescu M, Crisan D, Lupsor M, Constantin D, Dina L. Prevalence and associated risk factors of non-alcoholic fatty liver disease in hospitalized patients. J Gastrointestin Liver Dis. 2008;17(3):255\u201360.","journal-title":"J Gastrointestin Liver Dis"},{"issue":"47","key":"4271_CR19","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.3748\/wjg.v13.i47.6419","volume":"13","author":"Y-J Zhou","year":"2007","unstructured":"Zhou Y-J, Li Y-Y, Nie Y-Q, Ma J-X, Lu L-G, Shi S-L, et al. Prevalence of fatty liver disease and its risk factors in the population of South China. World J Gastroenterology: WJG. 2007;13(47):6419.","journal-title":"World J Gastroenterology: WJG"},{"key":"4271_CR20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cca.2014.08.042","volume":"438","author":"I Wakabayashi","year":"2015","unstructured":"Wakabayashi I, Daimon T. The cardiometabolic index as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus. Clin Chim Acta. 2015;438:274\u20138.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"4271_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12902-024-01828-6","volume":"25","author":"S Hou","year":"2025","unstructured":"Hou S, Wang Y, Wei Z, Li H, Fang H, Zhang T, Zhu Y, Cui L, Zhang L, Chen X. Cardiac metabolic index as a predictor of new-onset diabetes in non-alcoholic fatty liver disease patients: a longitudinal cohort analysis. BMC Endocr Disorders. 2025;25(1):13.","journal-title":"BMC Endocr Disorders"},{"key":"4271_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-018-1098-8","volume":"19","author":"H-Y Wang","year":"2018","unstructured":"Wang H-Y, Shi W-R, Yi X, Wang S-Z, Luan S-Y, Sun Y-X. Value of reduced glomerular filtration rate assessment with cardiometabolic index: insights from a population-based Chinese cohort. BMC Nephrol. 2018;19:1\u201311.","journal-title":"BMC Nephrol"},{"issue":"12","key":"4271_CR23","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.kjms.2016.10.003","volume":"32","author":"M Dursun","year":"2016","unstructured":"Dursun M, Besiroglu H, Otunctemur A, Ozbek E. Association between cardiometabolic index and erectile dysfunction: a new index for predicting cardiovascular disease. Kaohsiung J Med Sci. 2016;32(12):620\u20133.","journal-title":"Kaohsiung J Med Sci"},{"issue":"8","key":"4271_CR24","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1080\/00325481.2017.1375714","volume":"129","author":"H Wang","year":"2017","unstructured":"Wang H, Chen Y, Guo X, Chang Y, Sun Y. Usefulness of cardiometabolic index for the estimation of ischemic stroke risk among general population in rural China. Postgrad Med. 2017;129(8):834\u201341.","journal-title":"Postgrad Med"},{"issue":"3","key":"4271_CR25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/00325481.2018.1444901","volume":"130","author":"H Wang","year":"2018","unstructured":"Wang H, Chen Y, Sun G, Jia P, Qian H, Sun Y. Validity of cardiometabolic index, lipid accumulation product, and body adiposity index in predicting the risk of hypertension in Chinese population. Postgrad Med. 2018;130(3):325\u201333.","journal-title":"Postgrad Med"},{"issue":"1","key":"4271_CR26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12944-024-02027-x","volume":"23","author":"W-f Xi","year":"2024","unstructured":"Xi W-f, Yang A-m. Association between cardiometabolic index and controlled Attenuation parameter in US adults with NAFLD: findings from NHANES (2017\u20132020). Lipids Health Dis. 2024;23(1):40.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"4271_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12876-022-02099-y","volume":"22","author":"J Zou","year":"2022","unstructured":"Zou J, Xiong H, Zhang H, Hu C, Lu S, Zou Y. Association between the cardiometabolic index and non-alcoholic fatty liver disease: insights from a general population. BMC Gastroenterol. 2022;22(1):20.","journal-title":"BMC Gastroenterol"},{"key":"4271_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1004855","volume":"13","author":"S Duan","year":"2022","unstructured":"Duan S, Yang D, Xia H, Ren Z, Chen J, Yao S. Cardiometabolic index: a new predictor for metabolic associated fatty liver disease in Chinese adults. Front Endocrinol. 2022;13:1004855.","journal-title":"Front Endocrinol"},{"issue":"11","key":"4271_CR29","first-page":"750","volume":"17","author":"F Zamani","year":"2014","unstructured":"Zamani F, Sohrabi M, Alipour A, Motamed N, Saeedian FS, Pirzad R, et al. Prevalence and risk factors of cholelithiasis in Amol city, Northern Iran: a population based study. Arch Iran Med. 2014;17(11):750\u20134.","journal-title":"Arch Iran Med"},{"key":"4271_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1329380","volume":"15","author":"N Motamed","year":"2024","unstructured":"Motamed N, Zamani F, Maadi M, Ajdarkosh H, Roozafzai F, Keyvani H, et al. A population-based prospective study on obesity-related non-communicable diseases in Northern Iran: rationale, study design, and baseline analysis. Front Endocrinol (Lausanne). 2024;15:1329380.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"4271_CR31","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1159\/000539371","volume":"17","author":"D Liver EAftSot","year":"2024","unstructured":"Liver EAftSot D, EAftSo. Obesity eaftso: EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Obes Facts. 2024;17(4):374\u2013443.","journal-title":"Obes Facts"},{"issue":"1","key":"4271_CR32","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology. 2018;67(1):328\u201357.","journal-title":"Hepatology"},{"issue":"3","key":"4271_CR33","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/dme.13565","volume":"35","author":"A Sberna","year":"2018","unstructured":"Sberna A, Bouillet B, Rouland A, Brindisi M, Nguyen A, Mouillot T, Duvillard L, Denimal D, Loffroy R, Verg\u00e8s B. European association for the study of the liver (EASL), European association for the study of diabetes (EASD) and European association for the study of obesity (EASO) clinical practice recommendations for the management of non-alcoholic fatty liver disease: evaluation of their application in people with type 2 diabetes. Diabet Med. 2018;35(3):368\u201375.","journal-title":"Diabet Med"},{"issue":"26","key":"4271_CR34","doi-asserted-by":"publisher","first-page":"8377","DOI":"10.3748\/wjg.v20.i26.8377","volume":"20","author":"NC Leite","year":"2014","unstructured":"Leite NC, Villela-Nogueira CA, Cardoso CR, Salles GF. Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatment. World J Gastroenterology: WJG. 2014;20(26):8377.","journal-title":"World J Gastroenterology: WJG"},{"issue":"21","key":"4271_CR35","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.3390\/diagnostics13213316","volume":"13","author":"T Biciusca","year":"2023","unstructured":"Biciusca T, Stan SI, Balteanu MA, Cioboata R, Ghenea AE, Danoiu S, Bumbea A-M, Biciusca V. The role of the fatty liver index (FLI) in the management of non-alcoholic fatty liver disease: a systematic review. Diagnostics. 2023;13(21):3316.","journal-title":"Diagnostics"},{"issue":"6","key":"4271_CR36","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499\u2013502.","journal-title":"Clin Chem"},{"issue":"2","key":"4271_CR37","doi-asserted-by":"publisher","first-page":"106","DOI":"10.5812\/asjsm.34781","volume":"2","author":"A Vasheghani-Farahani","year":"2011","unstructured":"Vasheghani-Farahani A, Tahmasbi M, Asheri H, Ashraf H, Nedjat S, Kordi R. The Persian, last 7-day, long form of the international physical activity questionnaire: translation and validation study. Asian J Sports Med. 2011;2(2):106\u201316.","journal-title":"Asian J Sports Med"},{"issue":"1 Suppl","key":"4271_CR38","doi-asserted-by":"publisher","first-page":"2","DOI":"10.18553\/jmcp.2003.9.s1.2","volume":"9","author":"RJ Lipsy","year":"2003","unstructured":"Lipsy RJ. The national cholesterol education program adult treatment panel III guidelines. J Managed Care Pharmacy: JMCP. 2003;9(1 Suppl):2\u20135.","journal-title":"J Managed Care Pharmacy: JMCP"},{"issue":"5","key":"4271_CR39","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1017\/S1368980009991698","volume":"13","author":"P Mirmiran","year":"2010","unstructured":"Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M, Azizi F. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 2010;13(5):654\u201362.","journal-title":"Public Health Nutr"},{"issue":"213","key":"4271_CR40","first-page":"42","volume":"7","author":"M Ghaffarpour","year":"1999","unstructured":"Ghaffarpour M, Houshiar-Rad A, Kianfar H. The manual for household measures, cooking yields factors and edible portion of foods. Tehran: Nashre Olume Keshavarzy. 1999;7(213):42\u201358.","journal-title":"Tehran: Nashre Olume Keshavarzy"},{"key":"4271_CR41","unstructured":"Nutritionist I. N-squared computing. Silverton: Nutritionist IV 1998."},{"issue":"9596","key":"4271_CR42","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E Von Elm","year":"2007","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20137.","journal-title":"Lancet"},{"issue":"3","key":"4271_CR43","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/jn\/nxz270","volume":"150","author":"D Wang","year":"2020","unstructured":"Wang D, Karvonen-Gutierrez CA, Jackson EA, Elliott MR, Appelhans BM, Barinas-Mitchell E, et al. Western dietary pattern derived by multiple statistical methods is prospectively associated with subclinical carotid atherosclerosis in midlife women. J Nutr. 2020;150(3):579\u201391.","journal-title":"J Nutr"},{"issue":"1","key":"4271_CR44","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 1995;57(1):289\u2013300.","journal-title":"J R Stat Soc Series B Stat Methodol"},{"issue":"3","key":"4271_CR45","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/flgastro-2013-100403","volume":"5","author":"JK Dyson","year":"2014","unstructured":"Dyson JK, Anstee QM, McPherson S. Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging. Frontline Gastroenterol. 2014;5(3):211\u20138.","journal-title":"Frontline Gastroenterol"},{"issue":"12","key":"4271_CR46","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1136\/jclinpath-2013-201620","volume":"66","author":"J Dyson","year":"2013","unstructured":"Dyson J, McPherson S, Anstee Q. Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification. J Clin Pathol. 2013;66(12):1033\u201345.","journal-title":"J Clin Pathol"},{"issue":"3","key":"4271_CR47","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s13679-024-00574-z","volume":"13","author":"F Abdelhameed","year":"2024","unstructured":"Abdelhameed F, Kite C, Lagojda L, Dallaway A, Chatha KK, Chaggar SS, Dalamaga M, Kassi E, Kyrou I, Randeva HS. Non-invasive scores and serum biomarkers for fatty liver in the era of metabolic dysfunction-associated steatotic liver disease (MASLD): a comprehensive review from NAFLD to MAFLD and MASLD. Curr Obes Rep. 2024;13(3):510\u201331.","journal-title":"Curr Obes Rep"},{"issue":"7","key":"4271_CR48","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1210\/er.2008-0009","volume":"29","author":"N Stefan","year":"2008","unstructured":"Stefan N, Kantartzis K, H\u00e4ring H-U. Causes and metabolic consequences of fatty liver. Endocr Rev. 2008;29(7):939\u201360.","journal-title":"Endocr Rev"},{"issue":"2","key":"4271_CR49","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3126\/jcmsn.v13i2.17773","volume":"13","author":"KR Bhusal","year":"2017","unstructured":"Bhusal KR, Simkhada R, Nepal P. Lipid profile in different grades of ultrasonic non-alcoholic fatty liver disease. Journal of College of Medical Sciences-Nepal. 2017;13(2):258\u201361.","journal-title":"Journal of College of Medical Sciences-Nepal"},{"issue":"3","key":"4271_CR50","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","volume":"65","author":"G Targher","year":"2016","unstructured":"Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol. 2016;65(3):589\u2013600.","journal-title":"J Hepatol"},{"issue":"5","key":"4271_CR51","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/liv.12977","volume":"36","author":"Y Fukuda","year":"2016","unstructured":"Fukuda Y, Hashimoto Y, Hamaguchi M, Fukuda T, Nakamura N, Ohbora A, et al. Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population\u2010based cohort study. Liver Int. 2016;36(5):713\u201320.","journal-title":"Liver Int"},{"issue":"1","key":"4271_CR52","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.dsx.2018.10.006","volume":"13","author":"B Pantoja-Torres","year":"2019","unstructured":"Pantoja-Torres B, Toro-Huamanchumo CJ, Urrunaga-Pastor D, Guarnizo-Poma M, Lazaro-Alcantara H, Paico-Palacios S, et al. High triglycerides to HDL-cholesterol ratio is associated with insulin resistance in normal-weight healthy adults. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019;13(1):382\u20138.","journal-title":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews"},{"key":"4271_CR53","doi-asserted-by":"publisher","first-page":"1148934","DOI":"10.3389\/fendo.2023.1148934","volume":"14","author":"Y Chen","year":"2023","unstructured":"Chen Y, Wang W, Morgan MP, Robson T, Annett S. Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets. Front Endocrinol. 2023;14:1148934.","journal-title":"Front Endocrinol"},{"issue":"6","key":"4271_CR54","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.aohep.2019.07.004","volume":"18","author":"C Saitta","year":"2019","unstructured":"Saitta C, Pollicino T, Raimondo G. Obesity and liver cancer. Ann Hepatol. 2019;18(6):810\u20135.","journal-title":"Ann Hepatol"},{"issue":"11","key":"4271_CR55","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1161\/CIRCRESAHA.119.315896","volume":"126","author":"H Wu","year":"2020","unstructured":"Wu H, Ballantyne CM. Metabolic inflammation and insulin resistance in obesity. Circ Res. 2020;126(11):1549\u201364.","journal-title":"Circ Res"},{"issue":"1","key":"4271_CR56","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3748\/wjg.v22.i1.394","volume":"22","author":"H Sakai","year":"2016","unstructured":"Sakai H, Shirakami Y, Shimizu M. Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents. World J Gastroenterol. 2016;22(1):394.","journal-title":"World J Gastroenterol"},{"key":"4271_CR57","doi-asserted-by":"crossref","unstructured":"Fu S, Luo L, Ye P, Liu Y, Zhu B, Bai Y, Bai J. The abilities of new anthropometric indices in identifying cardiometabolic abnormalities, and influence of residence area and lifestyle on these anthropometric indices in a Chinese community-dwelling population. Clin Interv Aging . 2014; 9:179\u201389.","DOI":"10.2147\/CIA.S54240"},{"issue":"11","key":"4271_CR58","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3345\/kjp.2016.59.11.425","volume":"59","author":"E-G Yoo","year":"2016","unstructured":"Yoo E-G. Waist-to-height ratio as a screening tool for obesity and cardiometabolic risk. Korean J Pediatr. 2016;59(11):425.","journal-title":"Korean J Pediatr"},{"issue":"1","key":"4271_CR59","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3923\/pjn.2011.15.18","volume":"10","author":"U Odenigbo","year":"2011","unstructured":"Odenigbo U, Odenigbo U, Oguejiofor O, Adogu P. Relationship of waist circumference, waist hip ratio and body mass index as predictors of obesity in adult Nigerians. Pak J Nutr. 2011;10(1):15\u20138.","journal-title":"Pak J Nutr"},{"issue":"5","key":"4271_CR60","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/09637480500195066","volume":"56","author":"M Ashwell","year":"2005","unstructured":"Ashwell M, Hsieh SD. Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Int J Food Sci Nutr. 2005;56(5):303\u20137.","journal-title":"Int J Food Sci Nutr"},{"key":"4271_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-018-0886-2","volume":"17","author":"W-R Shi","year":"2018","unstructured":"Shi W-R, Wang H-Y, Chen S, Guo X-F, Li Z, Sun Y-X. Estimate of prevalent diabetes from cardiometabolic index in general Chinese population: a community-based study. Lipids Health Dis. 2018;17:1\u20139.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"4271_CR62","doi-asserted-by":"publisher","first-page":"4914791","DOI":"10.1155\/2022\/4914791","volume":"2022","author":"X Cai","year":"2022","unstructured":"Cai X, Hu J, Wen W, Wang J, Wang M, Liu S, Zhu Q, Hong J, Dang Y, Yao X. Associations of the cardiometabolic index with the risk of cardiovascular disease in patients with hypertension and obstructive sleep apnea: results of a longitudinal cohort study. Oxidative Med Cell Longev. 2022;2022(1):4914791.","journal-title":"Oxidative Med Cell Longev"},{"key":"4271_CR63","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.cca.2015.04.020","volume":"446","author":"I Wakabayashi","year":"2015","unstructured":"Wakabayashi I, Sotoda Y, Hirooka S, Orita H. Association between cardiometabolic index and atherosclerotic progression in patients with peripheral arterial disease. Clin Chim Acta. 2015;446:231\u20136.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"4271_CR64","doi-asserted-by":"publisher","first-page":"478","DOI":"10.15537\/smj.2025.46.5.20240901","volume":"46","author":"W Mohammedsaeed","year":"2025","unstructured":"Mohammedsaeed W, Al Malki A, Alsayed S. The risk factors for cardiovascular disease and chronic kidney disease in patients with nonalcoholic fatty liver disease in Saudi Arabia. Saudi Med J. 2025;46(5):478\u201390.","journal-title":"Saudi Med J"},{"issue":"4","key":"4271_CR65","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4254\/wjh.v12.i4.149","volume":"12","author":"L Lind","year":"2020","unstructured":"Lind L, Johansson L, Ahlstr\u00f6m H, Eriksson JW, Larsson A, Ris\u00e9rus U, Kullberg J, Oscarsson J. Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population. World J Hepatol. 2020;12(4):149.","journal-title":"World J Hepatol"},{"issue":"10","key":"4271_CR66","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1111\/apt.12963","volume":"40","author":"L Fedchuk","year":"2014","unstructured":"Fedchuk L, Nascimbeni F, Pais R, Charlotte F, Housset C, Ratziu V, et al. Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2014;40(10):1209\u201322.","journal-title":"Aliment Pharmacol Ther"},{"key":"4271_CR67","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.","journal-title":"BMC Gastroenterol"},{"issue":"11","key":"4271_CR68","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","volume":"2","author":"H Yki-J\u00e4rvinen","year":"2014","unstructured":"Yki-J\u00e4rvinen H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol. 2014;2(11):901\u201310.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7549","key":"4271_CR69","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1136\/bmj.332.7549.1080","volume":"332","author":"DG Altman","year":"2006","unstructured":"Altman DG, Royston P. The cost of dichotomising continuous variables. BMJ. 2006;332(7549):1080.","journal-title":"BMJ"},{"issue":"1","key":"4271_CR70","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12933-020-01025-4","volume":"19","author":"JH Kim","year":"2020","unstructured":"Kim JH, Moon JS, Byun SJ, Lee JH, Kang DR, Sung KC, Kim JY, Huh JH. Fatty liver index and development of cardiovascular disease in Koreans without pre-existing myocardial infarction and ischemic stroke: a large population-based study. Cardiovasc Diabetol. 2020;19(1):51.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"4271_CR71","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1080\/07853890.2021.1956685","volume":"53","author":"DJ Cuthbertson","year":"2021","unstructured":"Cuthbertson DJ, Koskinen J, Brown E, Magnussen CG, Hutri-K\u00e4h\u00f6nen N, Sabin M, et al. Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD). Ann Med. 2021;53(1):1257\u201365.","journal-title":"Ann Med"},{"key":"4271_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:1\u20137.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"4271_CR73","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13293-022-00475-7","volume":"13","author":"S Fresneda","year":"2022","unstructured":"Fresneda S, Abbate M, Busquets-Cort\u00e9s C, L\u00f3pez-Gonz\u00e1lez A, Fuster-Parra P, Bennasar-Veny M, et al. Sex and age differences in the association of fatty liver index-defined non-alcoholic fatty liver disease with cardiometabolic risk factors: a cross-sectional study. Biol Sex Differ. 2022;13(1):64.","journal-title":"Biol Sex Differ"},{"issue":"28","key":"4271_CR74","doi-asserted-by":"publisher","first-page":"9330","DOI":"10.3748\/wjg.v20.i28.9330","volume":"20","author":"S Mili\u0107","year":"2014","unstructured":"Mili\u0107 S, Luli\u0107 D, \u0160timac D. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterology: WJG. 2014;20(28):9330.","journal-title":"World J Gastroenterology: WJG"},{"issue":"3","key":"4271_CR75","doi-asserted-by":"publisher","first-page":"5880","DOI":"10.4238\/2014.August.7.3","volume":"13","author":"W Bi","year":"2014","unstructured":"Bi W, Yang C, Shi Q, Xu Y, Cao C, Ling J, Wang X. Large-scale analysis of factors influencing nonalcoholic fatty liver disease and its relationship with liver enzymes. Genet Mol Res. 2014;13(3):5880\u201391.","journal-title":"Genet Mol Res"},{"key":"4271_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-230X-13-3","volume":"13","author":"H Ma","year":"2013","unstructured":"Ma H, Xu C, Xu L, Yu C, Miao M, Li Y. Independent association of HbA1c and nonalcoholic fatty liver disease in an elderly Chinese population. BMC Gastroenterol. 2013;13:1\u20136.","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"4271_CR77","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3892\/br.2014.309","volume":"2","author":"M Tomizawa","year":"2014","unstructured":"Tomizawa M, Kawanabe Y, Shinozaki F, Sato S, Motoyoshi Y, Sugiyama T, et al. Triglyceride is strongly associated with nonalcoholic fatty liver disease among markers of hyperlipidemia and diabetes. Biomed Rep. 2014;2(5):633\u20136.","journal-title":"Biomed Rep"},{"issue":"3","key":"4271_CR78","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/metabo11030155","volume":"11","author":"A Armandi","year":"2021","unstructured":"Armandi A, Rosso C, Caviglia GP, Bugianesi E. Insulin resistance across the spectrum of nonalcoholic fatty liver disease. Metabolites. 2021;11(3):155.","journal-title":"Metabolites"},{"issue":"7","key":"4271_CR79","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1210\/jcem.87.7.8736","volume":"87","author":"A Garg","year":"2002","unstructured":"Garg A, Misra A. Hepatic steatosis, insulin resistance, and adipose tissue disorders. J Clin Endocrinol Metab. 2002;87(7):3019\u201322.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4271_CR80","first-page":"6676569","volume":"2021","author":"Y Yang","year":"2021","unstructured":"Yang Y, Wang B, Yuan H, Li X. Triglycerides to high-density lipoprotein cholesterol ratio is the best surrogate marker for insulin resistance in Nonobese middle\u2010aged and elderly population: a cross\u2010sectional study. Int J Endocrinol. 2021;2021(1):6676569.","journal-title":"Int J Endocrinol"},{"issue":"2","key":"4271_CR81","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/MED.0000000000000241","volume":"23","author":"R Quispe","year":"2016","unstructured":"Quispe R, Martin SS, Jones SR. Triglycerides to high-density lipoprotein\u2013cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes. Curr Opin Endocrinol Diabetes Obes. 2016;23(2):150\u20136.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"4271_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-019-0986-7","volume":"18","author":"N Fan","year":"2019","unstructured":"Fan N, Peng L, Xia Z, Zhang L, Song Z, Wang Y, et al. Triglycerides to high-density lipoprotein cholesterol ratio as a surrogate for nonalcoholic fatty liver disease: a cross-sectional study. Lipids Health Dis. 2019;18:1\u20136.","journal-title":"Lipids Health Dis"},{"issue":"5","key":"4271_CR83","doi-asserted-by":"publisher","first-page":"537","DOI":"10.5009\/gnl19236","volume":"14","author":"M Tobari","year":"2020","unstructured":"Tobari M, Hashimoto E. Characteristic features of nonalcoholic fatty liver disease in Japan with a focus on the roles of age, sex and body mass index. Gut Liver. 2020;14(5):537.","journal-title":"Gut Liver"},{"issue":"7","key":"4271_CR84","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/j.1478-3231.2006.01311.x","volume":"26","author":"S Zelber-Sagi","year":"2006","unstructured":"Zelber-Sagi S, Nitzan\u2010Kaluski D, Halpern Z, Oren R. Prevalence of primary non\u2010alcoholic fatty liver disease in a population\u2010based study and its association with biochemical and anthropometric measures. Liver Int. 2006;26(7):856\u201363.","journal-title":"Liver Int"},{"issue":"2","key":"4271_CR85","doi-asserted-by":"publisher","first-page":"51","DOI":"10.37349\/emed.2020.00005","volume":"1","author":"NC Salvoza","year":"2020","unstructured":"Salvoza NC, Giraudi PJ, Tiribelli C, Rosso N. Sex differences in non-alcoholic fatty liver disease: hints for future management of the disease. Exploration of Medicine. 2020;1(2):51\u201374.","journal-title":"Exploration of Medicine"},{"issue":"6","key":"4271_CR86","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1002\/hep.29068","volume":"65","author":"I Doycheva","year":"2017","unstructured":"Doycheva I, Watt KD, Alkhouri N. Nonalcoholic fatty liver disease in adolescents and young adults: the next frontier in the epidemic. Hepatology. 2017;65(6):2100\u20139.","journal-title":"Hepatology"},{"issue":"8","key":"4271_CR87","first-page":"0","volume":"17","author":"F Akbari","year":"2014","unstructured":"Akbari F, Azadbakht L. A systematic review on diet quality among Iranian youth: focusing on reports from Tehran and Isfahan. Arch Iran Med. 2014;17(8):0\u20130.","journal-title":"Arch Iran Med"},{"issue":"1","key":"4271_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33419-6","volume":"8","author":"R Fan","year":"2018","unstructured":"Fan R, Wang J, Du J. Association between body mass index and fatty liver risk: a dose-response analysis. Sci Rep. 2018;8(1):15273.","journal-title":"Sci Rep"},{"issue":"5","key":"4271_CR89","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1365-277X.2005.00634.x","volume":"18","author":"R Rocha","year":"2005","unstructured":"Rocha R, Cotrim HP, Carvalho F, Siqueira A, Braga H, Freitas L. Body mass index and waist circumference in non-alcoholic fatty liver disease. J Hum Nutr Diet. 2005;18(5):365\u201370.","journal-title":"J Hum Nutr Diet"},{"issue":"3\u20134","key":"4271_CR90","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2298\/SARH0804122M","volume":"136","author":"D Marovi\u0107","year":"2008","unstructured":"Marovi\u0107 D. Elevated body mass index and fatty liver. Srp Arh Celok Lek. 2008;136(3\u20134):122\u20135.","journal-title":"Srp Arh Celok Lek"},{"issue":"1","key":"4271_CR91","first-page":"45","volume":"25","author":"E Margariti","year":"2012","unstructured":"Margariti E, Deutsch M, Manolakopoulos S, Papatheodoridis GV. Non-alcoholic fatty liver disease may develop in individuals with normal body mass index. Ann Gastroenterol. 2012;25(1):45.","journal-title":"Ann Gastroenterol"},{"issue":"1","key":"4271_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plipres.2008.08.001","volume":"48","author":"G Musso","year":"2009","unstructured":"Musso G, Gambino R, Cassader M. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res. 2009;48(1):1\u201326.","journal-title":"Prog Lipid Res"},{"issue":"16","key":"4271_CR93","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMra011775","volume":"346","author":"P Angulo","year":"2002","unstructured":"Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346(16):1221\u201331.","journal-title":"N Engl J Med"},{"issue":"5","key":"4271_CR94","doi-asserted-by":"publisher","first-page":"994","DOI":"10.14309\/ajg.0000000000001072","volume":"116","author":"E Vilar-Gomez","year":"2021","unstructured":"Vilar-Gomez E, Pirola CJ, Sookoian S, Wilson LA, Belt P, Liang T, et al. Impact of the association between PNPLA3 genetic variation and dietary intake on the risk of significant fibrosis in patients with NAFLD. Am J Gastroenterol. 2021;116(5):994\u20131006.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"4271_CR95","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/hep4.1822","volume":"6","author":"F Luo","year":"2022","unstructured":"Luo F, Oldoni F, Das A. TM6SF2: a novel genetic player in nonalcoholic fatty liver and cardiovascular disease. Hepatol Commun. 2022;6(3):448\u201360.","journal-title":"Hepatol Commun"},{"issue":"1","key":"4271_CR96","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13098-022-00814-z","volume":"14","author":"JK DiStefano","year":"2022","unstructured":"DiStefano JK, Gerhard GS. NAFLD in normal weight individuals. Diabetol Metab Syndr. 2022;14(1):45.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"4271_CR97","doi-asserted-by":"publisher","first-page":"13194","DOI":"10.1038\/s41598-024-64034-3","volume":"14","author":"L Yan","year":"2024","unstructured":"Yan L, Hu X, Wu S, Cui C, Zhao S. Association between the cardiometabolic index and NAFLD and fibrosis. Sci Rep. 2024;14(1):13194.","journal-title":"Sci Rep"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04271-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04271-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04271-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T01:04:20Z","timestamp":1760490260000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04271-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":97,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4271"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04271-6","relation":{},"ISSN":["1471-230X"],"issn-type":[{"type":"electronic","value":"1471-230X"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical standards of the Declaration of Helsinki and was approved by the Ethics Committee of Iran University of Medical Sciences (IR.IUMS.REC.1400.982). All participants read and signed the informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"729"}}